Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-018625

Options or other derivatives

  • Chief Financial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Slover Peter T · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-24 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X05/rdgdoc.xml…